PCM
LOXO

Palisade Capital Management’s Loxo Oncology, Inc LOXO Stock Holding History

Palisade Capital Management’s Portfolio LOXO Stock Details LOXO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-1,300
Closed -$226K – 482
2018
Q2 		$226K Buy
+1,300
New +$195K 0.01% 436

Other funds holding LOXO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
AC
Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Palisade Capital Management's LOXO Position: Q3 2018 in Review

Palisade Capital Management sold out of Loxo Oncology, Inc (LOXO) in Q3 2018, closing a stake of 1,300 shares — an estimated $226K sold.

Palisade Capital Management first reported a position in LOXO in Q2 2018 and held it in 1 quarter. The position peaked at $226K in Q2 2018. 228 funds tracked by Wall St. Rank hold LOXO as of Q3 2018.

  • Palisade Capital Management reported no remaining Loxo Oncology, Inc position as of Q3 2018 after selling out during the quarter.
  • Palisade Capital Management sold 1,300 Loxo Oncology, Inc shares in Q3 2018, an estimated $226K.
  • Palisade Capital Management first reported a position in Loxo Oncology, Inc in Q2 2018 and held it in 1 quarter.
  • Palisade Capital Management's Loxo Oncology, Inc position peaked at $226K in Q2 2018.
  • 228 funds tracked by Wall St. Rank held Loxo Oncology, Inc as of Q3 2018.

Based on Palisade Capital Management's 13F filing for Q3 2018, filed 14 Nov 2018.